News

Dr. Reddy's Laboratories, TCS and Wipro to see some action today

Dhampur Sugar Mills’ board has approved the expansion of Sugar Units Capacity by 1,500 Tonnes Crushing Per Day each at Asmoli unit

Dr. Reddy's Laboratories has re-launched over-the-counter {OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). The re-launch of Dr. Reddy's Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products.

Tata Consultancy Services (TCS) has been enlisted by Rich Productsto drive its end-to-end supply chain transformation, enhancing integrated planning and agility, and helping it meet changing customer demands.

Wipro has earned the Kubernetes on Microsoft Azure advanced specialization, a validation of a solution partner's deep knowledge, extensive experience and proven expertise in deploying and managing production workloads in the cloud using containers and managing hosted Kubernetes environments in Microsoft Azure.

Dhampur Sugar Mills’ board has approved the expansion of Sugar Units Capacity by 1,500 Tonnes Crushing Per Day (TCD) each at Asmoli unit from 9,000 TCD to 10,500 TCD and Meerganj unit from 5,000 TCD to 6,500 TCD of the Company. With the proposed expansion, the total capacity of the Company will stand augmented from 45,500 TCD to 48,500 TCD.

G R Infraprojects has received Letter of Acceptance (LoA) for Construction of Elevated Structures (Viaduct & stations) of length 7.50Km (approx.) from Gottigere to Swagath Road Cross (Chainage 00.00m to 7501.818m) including Kothnur Depot entry line, Road widening & allied works and 5 Numbers of Metro Stations viz, Gottigere, Hulimavu, IIMB, JP Nagar 4th Phase, Swagath Road Cross in Reach-6 line of Bangalore Metro Rail Project, Phase - 2 (Balance Works).

ICICI Prudential Life Insurance has tied up with the National Payments Corporation of India (NPCI) to provide Unified Payments Interface (UPI) AUTOPAY facility to its customers. This would enable customers to buy insurance policies and make premium payments from the safety and comfort of their homes.

India Pesticides’ board has considered and approved the further investment of Rs. 2.30 crore in Shalvis Specialities, wholly owned subsidiary of the Company, by way of subscription to equity shares through Rights Issue. The Board of Directors of the company in their meeting held on July 22, 2021, has considered and approved the same.